who is a good candidate for glp-1 Semaglutide vs Tirzepatide: Which Right You? – Calibrate IV Who's a Good Candidate for

Drug interactions are most clinically important with insulin and sulfonylureas (hypoglycaemia risk), DPP-4 inhibitors (dont combine), and (for Mounjaro only) oral contraceptives and oral HRT

Allegations of Undisclosed Risks Plaintiffs assert that the manufacturers of Ozempic, Wegovy, Mounjaro, Victoza, Saxenda, Rybelsus, and other GLP-1 agonists failed to adequately warn consumers about the risk of these potentially life-altering side effects

doi: 10.2174/0929867328666211213112949 106 JinBJiFZuoALiuHQiLHeYet al

There are no sourcing links for these claims, and the Best of 2025 badges on two different medications dont add up though some claims are verifiable

As a weight loss coach who has been leading people in weight loss for over ten years, plus my experience of maintaining my weight loss for 20+ years, Ive researched this topic extensively